Huang CS - Search Results

1

Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast--a review of 42 primary and secondary cases in Taiwanese patients.

Lin YC, Tsai CH, Wu JS, Huang CS, Kuo SH, Lin CW, Cheng AL. Lin YC, et al. Among authors: huang cs. Leuk Lymphoma. 2009 Jun;50(6):918-24. doi: 10.1080/10428190902777475. Leuk Lymphoma. 2009. PMID: 19373599

2

Prognostic factors for the survival of Taiwanese breast cancer patients.

Chie WC, Chang SH, Huang CS, Tzeng SJ, Chen JH, Fan BY, Chang KJ. Chie WC, et al. Among authors: huang cs. J Formos Med Assoc. 2002 Feb;101(2):98-103. J Formos Med Assoc. 2002. PMID: 12099211

3

Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.

Hsu C, Huang CS, Chao TY, Lu YS, Bu CF, Chen MM, Chang KJ, Cheng AL. Hsu C, et al. Among authors: huang cs. Cancer. 2002 Nov 15;95(10):2044-50. doi: 10.1002/cncr.10951. Cancer. 2002. PMID: 12412156 Free article. Clinical Trial.

4

Recent advances in the management of primary breast cancers.

Lu YS, Kuo SH, Huang CS. Lu YS, et al. Among authors: huang cs. J Formos Med Assoc. 2004 Aug;103(8):579-98. J Formos Med Assoc. 2004. PMID: 15340657 Review.

5

p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.

Lien HC, Lin CW, Mao TL, Kuo SH, Hsiao CH, Huang CS. Lien HC, et al. Among authors: huang cs. J Pathol. 2004 Oct;204(2):131-9. doi: 10.1002/path.1624. J Pathol. 2004. PMID: 15376261

6

A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.

Lin CC, Cheng AL, Hsu CH, Lu YS, Hsu C, Yeh KH, Wu CY, Huang CS, Yang CH. Lin CC, et al. Among authors: huang cs. Anticancer Res. 2007 Jan-Feb;27(1B):641-5. Anticancer Res. 2007. PMID: 17348454 Free article. Clinical Trial.

7

Should adjuvant radiotherapy to the supraclavicular fossa be routinely given in patients with breast conservative treatment?

Wang CW, Kuo WH, Chang KJ, Huang CS, Cheng JC. Wang CW, et al. Among authors: huang cs. J Surg Oncol. 2007 Aug 1;96(2):144-50. doi: 10.1002/jso.20791. J Surg Oncol. 2007. PMID: 17443743

8

Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients.

Kuo SH, Lien HC, You SL, Lu YS, Lin CH, Chen TZ, Huang CS. Kuo SH, et al. Among authors: huang cs. Breast. 2008 Dec;17(6):646-53. doi: 10.1016/j.breast.2008.05.006. Epub 2008 Jul 1. Breast. 2008. PMID: 18595699

9

The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.

Huang CS, Kuo SH, Lien HC, Yang SY, You SL, Shen CY, Lin CH, Lu YS, Chang KJ. Huang CS, et al. Oncologist. 2008 Jul;13(7):751-60. doi: 10.1634/theoncologist.2007-0246. Epub 2008 Jul 9. Oncologist. 2008. PMID: 18614591 Free article.

10

Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence.

Kuo SH, Huang CS, Kuo WH, Cheng AL, Chang KJ, Chia-Hsien Cheng J. Kuo SH, et al. Among authors: huang cs. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1456-64. doi: 10.1016/j.ijrobp.2008.03.042. Epub 2008 Aug 7. Int J Radiat Oncol Biol Phys. 2008. PMID: 18692329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,199 results

Search Page

Filters